Transport pathways and enhancement mechanisms within localized and non-localized transport regions in skin treated with low-frequency sonophoresis and sodium lauryl sulfate

Journal of Pharmaceutical Sciences

Volumn 100, Issue 2, 2011, Pages 512-529

  Polat, Baris E ^a   Figueroa, Pedro L ^a   Blankschtein, Daniel ^a   Langer, Robert ^a  

^a Massachusetts Institute of Technology Cambridge   (United States)

Author keywords

Diffusion; Permeability; Permeation enhancers; Skin; Surfactants; Transdermal; Transdermal drug delivery; Ultrasound

Indexed keywords

CALCEIN; DODECYL SULFATE SODIUM;

ANIMAL TISSUE; ARTICLE; DERMIS; LOW FREQUENCY SONOPHORESIS; NONHUMAN; SKIN; SKIN PENETRATION; SKIN PERMEABILITY; SWINE; TRANSDERMAL DRUG ADMINISTRATION; ULTRASOUND;

EID: 78650529814     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22280     Document Type: Article

References (56)

1. Escobar-Chavez J, Bonilla-Martínez D, Villegas-González M, Rodríguez-Cruz I, Domínguez-Delgado C. 2009. The use of sonophoresis in the administration of drugs throughout the skin. J Pharm Pharm Sci 12(1):88.
2. Levy D, Kost J, Meshulam Y, Langer R. 1989. Effect of ultrasound on transdermal drug delivery to rats and guinea pigs. J Clin Invest 83(6):2074.
3. Mitragotri S, Blankschtein D, Langer R. 1995. Ultrasound-mediated transdermal protein delivery. Science 269(5225):850-853.
4. Johnson ME, Mitragotri S, Patel A, Blankschtein D, Langer R. 1996. Synergistic effects of chemical enhancers and therapeutic ultrasound on transdermal drug delivery. J Pharm Sci 85(7):670-679.
5. Tezel A, Mitragotri S. 2003. Interactions of inertial cavitation bubbles with stratum corneum lipid bilayers during low-frequency sonophoresis. Biophys J 85(6):3502-3512.
6. Tezel A, Sens A, Mitragotri S. 2002. Investigations of the role of cavitation in low-frequency sonophoresis using acoustic spectroscopy. J Pharm Sci 91(2):444-453.
7. Terahara T, Mitragotri S, Langer R. 2002. Porous resins as a cavitation enhancer for low-frequency sonophoresis. J Pharm Sci 91(3):753-759.
8. Tang H, Wang CC, Blankschtein D, Langer R. 2002. An investigation of the role of cavitation in low-frequency ultrasound-mediated transdermal drug transport. Pharm Res 19(8):1160-1169.
9. Mitragotri S, Blankschtein D, Langer R. 1996. Transdermal drug delivery using low-frequency sonophoresis. Pharm Res 13(3):411-420.
10. Gaertner W. 1954. Frequency dependence of ultrasonic cavitation. J Acoust Soc Am 26(6):977-980.
11. Khabeev NS. 2006. Resonance properties of soluble gas bubbles. Int J Heat Mass Transf 49(5-6):1022-1026.
12. Leighton TG, Walton AJ, Pickworth MJW. 1990. Primary Bjerknes forces. Eur J Phys 11:47-50.
13. Mitragotri S, Ray D, Farrell J, Tang H, Yu B, Kost J, Blankschtein D, Langer R. 2000. Synergistic effect of low-frequency ultrasound and sodium lauryl sulfate on transdermal transport. J Pharm Sci 89(7):892-900.
14. Kushner J, Blankschtein D, Langer R. 2004. Experimental demonstration of the existence of highly permeable localized transport regions in low-frequency sonophoresis. J Pharm Sci 93(11):2733-2745.
15. Tezel A, Sens A, Tuchscherer J, Mitragotri S. 2002. Synergistic effect of low-frequency ultrasound and surfactants on skin permeability. J Pharm Sci 91(1):91-100.
16. Kushner J, Blankschtein D, Langer R. 2008. Evaluation of hydrophilic permeant transport parameters in the localized and non-localized transport regions of skin treated simultaneously with low-frequency ultrasound and sodium lauryl sulfate. J Pharm Sci 97(2):906-918.
17. Kushner J, Kim D, So PT, Blankschtein D, Langer RS. 2007. Dual-channel two-photon microscopy study of transdermal transport in skin treated with low-frequency ultrasound and a chemical enhancer. J Invest Dermatol 127(12):2832-2846.
18. Tezel A, Dokka S, Kelly S, Hardee GE, Mitragotri S. 2004. Topical delivery of anti-sense oligonucleotides using low-frequency sonophoresis. Pharm Res 21(12):2219-2225.
19. Tezel A, Sens A, Mitragotri S. 2002. A theoretical analysis of low-frequency sonophoresis: Dependence of transdermal transport pathways on frequency and energy density. Pharm Res 19(12):1841-1846.
20. Tezel A, Sens A, Tuchscherer J, Mitragotri S. 2001. Frequency dependence of sonophoresis. Pharm Res 18(12):1694-1700.
21. Kushner J, Blankschtein D, Langer R. 2008. Heterogeneity in skin treated with low-frequency ultrasound. J Pharm Sci 97(10):4119-4128.
22. Tang H, Mitragotri S, Blankschtein D, Langer R. 2001. Theoretical description of transdermal transport of hydrophilic permeants: Application to low-frequency sonophoresis. J Pharm Sci 90(5):545-568.
23. Kushner J, Blankschtein D, Langer R. 2007. Evaluation of the porosity, the tortuosity, and the hindrance factor for the transdermal delivery of hydrophilic permeants in the context of the aqueous pore pathway hypothesis using dual-radiolabeled permeability experiments. J Pharm Sci 96(12):3263-3282.
24. Syracuse Research Corporation. Interactive physical properties database demo. Accessed May 18, 2010, at.
25. Karande P, Jain A, Mitragotri S. 2006. Relationships between skin's electrical impedance and permeability in the presence of chemical enhancers. J Control Release 110(2):307-313.
26. Tang H, Blankschtein D, Langer R. 2002. Effects of low-frequency ultrasound on the transdermal permeation of mannitol: Comparative studies with in vivo and in vitro skin. J Pharm Sci 91(8):1776-1794.
27. Kasting GB, Bowman LA. 1990. DC electrical properties of frozen, excised human skin. Pharm Res 7(2):134-143.
28. Kasting GB, Bowman LA. 1990. Electrical analysis of fresh, excised human skin-a comparison with frozen skin. Pharm Res 7(11):1141-1146.
29. Rosell J, Colominas J, Riu P, Pallasareny R, Webster JG. 1988. Skin impedance from 1 Hz to 1 MHz. IEEE Trans BioMed Eng 35(8):649-651.
30. Anderson R. 1993. Optics of the skin. Clin Photomed 19-35.
31. Anderson R, Parrish J. 1981. The optics of human skin. J Invest Dermatol 77(1):13-19.
32. Bashkatov A, Genina E, Kochubey V, Tuchin V. 2005. Optical properties of human skin, subcutaneous and mucous tissues in the wavelength range from 400 to 2000 nm. J Phys D Appl Phys 38:2543.
33. Jacques S. 1996. Origins of tissue optical properties in the UVA, visible, and NIR regions. Adv Opt Imaging Photon Migration 2:364-370.
34. Meglinski I, Matcher S. 2002. Quantitative assessment of skin layers absorption and skin reflectance spectra simulation. Physiol Meas 23:741-753.
35. Dechadilok P, Deen WM. 2006. Hindrance factors for diffusion and convection in pores. Ind Eng Chem Res 45(21):6953-6959.
36. Tezel A, Sens A, Mitragotri S. 2003. Description of transdermal transport of hydrophilic solutes during low-frequency sonophoresis based on a modified porous pathway model. J Pharm Sci 92(2):381-393.
37. Tezel A, Sens A, Mitragotri S. 2002. Incorporation of lipophilic pathways into the porous pathway model for describing skin permeabilization during low-frequency sonophoresis. J Control Release 83(1):183-188.
38. Seto J, Polat B, Lopez R, Blankschtein D, Langer R. Effects of ultrasound and sodium lauryl sulfate on the transdermal delivery of hydrophilic permeants: Comparative in vitro studies with full-thickness and split-thickness pig and human skin. J Control Release 145:26-32.
39. Edwards DA, Prausnitz MR, Langer R, Weaver JC. 1995. Analysis of enhanced transdermal transport by skin electroporation. J Control Release 34(3):211-221.
40. Johnson ME, Blankschtein D, Langer R. 1997. Evaluation of solute permeation through the stratum corneum: Lateral bilayer diffusion as the primary transport mechanism. J Pharm Sci 86(10):1162-1172.
41. Ghosh S, Blankschtein D. 2007. The role of sodium dodecyl sulfate (SDS) micelles in inducing skin barrier perturbation in the presence of glycerol. Int J Cosmet Sci 30:73-73.
42. Ghosh S, Blankschtein D. 2007. Why is sodium cocoyl isethionate (SCI) mild to the skin barrier? An in vitro investigation based on the relative sizes of the SCI micelles and the skin aqueous pores. J Cosmet Sci 58(3):229-244.
43. Moore PN, Puvvada S, Blankschtein D. 2003. Challenging the surfactant monomer skin penetration model: Penetration of sodium dodecyl sulfate micelles into the epidermis. J Cosmet Sci 54:29-46.
44. Simonin J-P. 1995. On the mechanisms of in vitro and in vivo phonophoresis. J Control Release 33(1):125-141.
45. Fong SW, Klaseboer E, Turangan CK, Khoo BC, Hung KC. 2006. Numerical analysis of a gas bubble near bio-materials in an ultrasound field. Ultrasound Med Biol 32(6):925-942.
46. Prausnitz MR, Mitragotri S, Langer R. 2004. Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov 3(2):115-124.
47. Khabeev NS. 1981. Resonance properties of vapor bubbles. J Appl Math Mech-Uss 45(4):512-517.
48. Ueda H, Mutoh M, Seki T, Kobayashi D, Morimoto Y. 2009. Acoustic cavitation as an enhancing mechanism of low-frequency sonophoresis for transdermal drug delivery. Biol Pharm Bull 32(5):916-920.
49. Tsochatzidis NA, Guiraud P, Wilhelm AM, Delmas H. 2001. Determination of velocity, size and concentration of ultrasonic cavitation bubbles by the phase-Doppler technique. Chem Eng Sci 56(5):1831-1840.
50. Burdin F, Tsochatzidis NA, Guiraud P, Wilhelm AM, Delmas H. 1999. Characterisation of the acoustic cavitation cloud by two laser techniques. Ultrason Sonochem 6(1-2):43-51.
51. Kodama T, Tomita Y. 2000. Cavitation bubble behavior and bubble-shock wave interaction near a gelatin surface as a study of in vivo bubble dynamics. Appl Phys B Lasers Opt 70(1):139-149.
52. Shergold O, Fleck N. 2004. Mechanisms of deep penetration of soft solids, with application to the injection and wounding of skin. P Roy Soc Lond A Mat 460(2050):3037.
53. Shergold O, Fleck N. 2005. Experimental investigation into the deep penetration of soft solids by sharp and blunt punches, with application to the piercing of skin. J Biomech Eng Trans ASME 127:838-848.
54. Roxhed N, Gasser T, Griss P, Holzapfel G, Stemme G. 2007. Penetration-enhanced ultrasharp microneedles and prediction on skin interaction for efficient transdermal drug delivery. J Microelectromech S 16(6):1429.
55. Shergold OA, Fleck NA, King TS. 2006. The penetration of a soft solid by a liquid jet, with application to the administration of a needle-free injection. J Biomech 39(14):2593-2602.
56. Schramm-Baxter J, Mitragotri S. 2004. Needle-free jet injections: Dependence of jet penetration and dispersion in the skin on jet power. J Control Release 97(3):527-535.